Uipath (PATH) | Stock Overview & Key Data
Uipath Performance Comparison
Stock Range
Today's Range
Low: $10.88
High: $11.24
on August 22, 2025
52 Week Range
Low: $9.38
High: $15.93
on April 7, 2025
on December 9, 2024
All-Time High: $90.00 on May 24, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$5.9B
EPS
-0.12
P/E Ratio (TTM)
-83.65
Forward P/E
24.98
P/B Ratio
3.46
PEG Ratio
4.18
Div. Yield
N/A
ROE
-3.62%
Beta
1.026
Debt to Equity
4.65
Financial Highlights
Profitability
Gross Margin
82.09%
Operating Margin
-3.76%
Profit Margin
-4.65%
Returns and Earnings
Return on Assets (TTM)
-2.32%
Return on Equity (TTM)
-3.62%
EBITDA
$-88.6M
Net Income (TTM)
$-67.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$2.62
Quarterly Revenue Growth (YoY)
6.40%
Quarterly Earnings Growth (YoY)
6.42%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Uipath PATH | 5.88B Mid-cap | 1.92% | -11.28% | -9.48% | -15.63% | -13.61% | -9.99% | -34.10% | -85.07% |
| Microsoft MSFT | 3.82T Mega-cap | -2.49% | 0.39% | 11.51% | 25.55% | 21.18% | 21.70% | 89.20% | 121.58% |
| Oracle ORCL | 659.01B Mega-cap | -4.80% | -0.73% | 50.26% | 39.07% | 42.37% | 69.82% | 216.64% | 308.38% |
| Amdocs DOX | 9.68B Mid-cap | 1.04% | -1.35% | -3.66% | -0.05% | 4.88% | 3.32% | 2.25% | 45.11% |
| Klaviyo KVYO | 9.61B Mid-cap | 4.26% | 0.06% | -2.76% | -21.17% | -21.30% | 0.28% | -1.86% | -1.86% |
| Shift4 Payments FOUR | 7.97B Mid-cap | 0.31% | -14.66% | 4.10% | -6.04% | -15.89% | 12.33% | 98.50% | 77.50% |
Ownership & Short Interest
Insider Ownership
8.27%
Institutional Ownership
81.73%
Shares Short
55M
Short Ratio
4.37
Short % of Shares Outstanding
15.10%
Average 10-Day Volume
10M
Average 90-Day Volume
13M
Uipath Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Uipath would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PATH's 52-week high and low?
- In the last 52 weeks, Uipath reached a high of $15.93 (on December 9, 2024) and a low of $9.38 (on April 7, 2025).
- What is the market cap and P/E ratio for PATH?
- Curious about Uipath's size and valuation? Its market capitalization stands at 5.88B. When it comes to valuation, the P/E ratio (trailing twelve months) is -83.65, and the forward P/E (looking ahead) is 24.98.
- Does PATH pay dividends? If so, what's the yield?
- As for dividends, Uipath isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Uipath's main competitors or similar companies to consider before investing?
When looking at Uipath, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Microsoft
MSFT3.82T Technology Software - Infrastructure 21.70% 89.20% Oracle
ORCL659.01B Technology Software - Infrastructure 69.82% 216.64% Amdocs
DOX9.68B Technology Software - Infrastructure 3.32% 2.25% Klaviyo
KVYO9.61B Technology Software - Infrastructure 0.28% -1.86% Shift4 Payments
FOUR7.97B Technology Software - Infrastructure 12.33% 98.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Uipath Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Uipath's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -3.62%, the Debt to Equity ratio from the most recent quarter is 4.65, and its Gross Profit Margin stands at 82.09%.
- What is the recent revenue and earnings growth for PATH?
- Looking at Uipath's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.40%, and quarterly earnings saw a YoY growth of 6.42%.
- How much of PATH stock is held by insiders and institutions?
- Wondering who owns Uipath stock? Company insiders (like executives and directors) hold about 8.27% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 81.73%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.